Scarica l'app Stockscreener
715.74
0.69%
4.92
Dopo l'orario di chiusura:
715.74
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$710.82
Aprire:
$710.87
Volume 24 ore:
412.58K
Relative Volume:
0.48
Capitalizzazione di mercato:
$89.40B
Reddito:
$359.05B
Utile/perdita netta:
$3.30B
Rapporto P/E:
27.71
EPS:
25.83
Flusso di cassa netto:
$5.23B
1 W Prestazione:
-1.58%
1M Prestazione:
-0.53%
6M Prestazione:
+20.25%
1 anno Prestazione:
+22.57%
Intervallo 1D:
$707.16
$715.99
Intervallo di 1 settimana:
$705.75
$728.37
Portata 52W:
$464.42
$737.89
Mckesson Corporation Stock (MCK) Company Profile
Nome
Mckesson Corporation
Settore
Industria
Telefono
972-446-4800
Indirizzo
6555 STATE HIGHWAY 161, IRVING, TX
Confronta MCK con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MCK
Mckesson Corporation
|
715.74 | 90.44B | 359.05B | 3.30B | 5.23B | 25.83 |
|
COR
Cencora Inc
|
297.83 | 57.77B | 310.23B | 1.69B | 3.58B | 8.62 |
|
CAH
Cardinal Health Inc
|
161.11 | 39.25B | 222.29B | 1.56B | 2.44B | 6.41 |
|
HSIC
Henry Schein Inc
|
69.32 | 9.24B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.751 | 514.48M | 2.22M | -5.63M | -1.68M | -0.24 |
Mckesson Corporation Stock (MCK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-04 | Ripresa | Mizuho | Neutral |
| 2024-11-07 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2024-09-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-09-05 | Reiterato | Leerink Partners | Outperform |
| 2024-08-08 | Reiterato | Mizuho | Neutral |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-12-14 | Iniziato | Wells Fargo | Equal Weight |
| 2023-03-31 | Iniziato | Citigroup | Buy |
| 2022-08-22 | Ripresa | Morgan Stanley | Overweight |
| 2022-07-06 | Downgrade | Argus | Buy → Hold |
| 2022-06-07 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2022-04-01 | Ripresa | Credit Suisse | Outperform |
| 2022-02-04 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-01-07 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2021-11-02 | Reiterato | Barclays | Overweight |
| 2021-11-02 | Reiterato | BofA Securities | Buy |
| 2021-11-02 | Reiterato | Evercore ISI | Outperform |
| 2021-11-02 | Reiterato | Jefferies | Buy |
| 2021-03-30 | Aggiornamento | Argus | Hold → Buy |
| 2020-11-02 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2020-08-04 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2020-05-22 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2020-05-15 | Aggiornamento | UBS | Neutral → Buy |
| 2020-04-23 | Ripresa | Credit Suisse | Neutral |
| 2020-03-18 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-03-13 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-02-07 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2020-01-10 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-12 | Iniziato | Deutsche Bank | Hold |
| 2019-08-05 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2019-07-22 | Iniziato | Guggenheim | Neutral |
| 2019-01-17 | Iniziato | UBS | Neutral |
| 2018-10-26 | Reiterato | Barclays | Equal Weight |
| 2018-07-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2018-05-29 | Reiterato | Leerink Partners | Mkt Perform |
| 2018-03-08 | Iniziato | Barclays | Equal Weight |
| 2018-02-27 | Ripresa | BofA/Merrill | Buy |
| 2018-02-02 | Reiterato | Mizuho | Neutral |
| 2018-01-24 | Aggiornamento | Jefferies | Hold → Buy |
Mostra tutto
Mckesson Corporation Borsa (MCK) Ultime notizie
McKesson (MCK): Morgan Stanley Raises Price Target to $810 | MCK Stock News - GuruFocus
McKesson (MCK) Sees Price Target Boost from Morgan Stanley | MCK Stock News - GuruFocus
McKesson ideaShare Empowers Independent Pharmacies to Innovate and Thrive - Yahoo Finance
Mckesson CEO Tyler S. Brian sells $13.7m in stock By Investing.com - Investing.com India
Mckesson CEO Tyler S. Brian sells $13.7m in stock - Investing.com
Synergy (NASDAQ: SNYR) Strategic Partnership w/ McKesson - openPR.com
Conference Recap: McKesson ideaShare Showcases Power of Independent Pharmacies - Drug Topics
McKesson (MCK) Partners with Synergy CHC for Canadian Distributi - GuruFocus
Synergy CHC Corp. (NASDAQ: SNYR) Secures Retail Deals with McKesson Canada and Others as FOCUSfactor Expansion Surges Across North America - The Manila Times
FOCUSfactor Secures Massive Retail Expansion: McKesson Canada Deal Opens Thousands of New Locations - Stock Titan
Government Contract Update: $1B payment to MCKESSON CORPORATION - Quiver Quantitative
McKesson ideaShare 2025: Pharmacy of the Year Finalist Keri Bates Reflects on Teamwork, Community, and the Road Ahead - Pharmacy Times
Independent Pharmacies Face Mounting Challenges in Modern Health Care Landscape | McKesson ideaShare - Drug Topics
McKesson Corporation (MCK): If It Was Down, I’d Say “Fill Her Up,” Says Jim Cramer - MSN
McKesson's Commitment to Independent Community Pharmacies Takes Center Stage | McKesson ideaShare - Drug Topics
McKesson ideaShare 2025: Pharmacy Technicians Drive Efficiency and Care - Pharmacy Times
Expert Discusses McKesson's Approach to Supporting Community Pharmacies | McKesson ideaShare - Drug Topics
Evercore ISI Issues Positive Forecast for McKesson (NYSE:MCK) Stock Price - MarketBeat
How McKesson Ruling Will Inform Interpretations Of The TCPA - Law360
Financial Planning Remains Core Focus to Create Thriving Pharmacy Business | McKesson ideaShare - Drug Topics
Is McKesson Corporation (NYSE:MCK) Trading At A 34% Discount? - Yahoo Finance
Evercore ISI Adjusts Price Target on McKesson to $800 From $760, Maintains Outperform Rating - MarketScreener
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
McKesson stock hits all-time high, reaching $737.0 USD - Investing.com
Why Investors Shouldn't Be Surprised By McKesson Corporation's (NYSE:MCK) P/E - simplywall.st
Why McKesson (MCK) is a Top Value Stock for the Long-Term - Yahoo Finance
Here's Why McKesson (MCK) is a Strong Growth Stock - Yahoo Finance
McKesson (MCK) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance
Nimesh Jhaveri - McKesson
McLaughlin v. McKesson: Rebalancing the Scales Between Agency and Judicial Interpretation of the TCPA - Womble Bond Dickinson
Biologics by McKesson: Personalized Patient Care - McKesson
McKesson Newsroom: Latest Updates & Announcements - McKesson
Pharmaceutical Distribution & Solutions - McKesson
McKesson Supports Health System Pharmacy to Achieve More - McKesson
McKesson Business Solutions & GPO Strategies - McKesson
Maria N. Martinez - McKesson
Brian S. Tyler - McKesson
Calls of the Day: ServiceNow, S&P Global, McKesson Corp., Ross Stores, TJX and Burlington - CNBC
Atlas Specialty: Navigating Specialty Pharmacies - McKesson
W. Roy Dunbar - McKesson
McKesson's Impact: Safety, Preparedness & Opioids - McKesson
Mark Edwards - McKesson
Deborah Dunsire, M.D. - McKesson
Kathleen Wilson-Thompson - McKesson
Dave Ehlert - McKesson
Heather Easterling - McKesson
Joe DePinto, MBA - McKesson
Ginger Thorpe - McKesson
Oncology & Specialty Drug Distribution - McKesson
Francisco FragaExecutive Vice President, Chief Information Officer and Chief Technology Officer - McKesson
5 Ways McKesson is Globally Supporting COVID-19 Vaccination Efforts - McKesson
Mckesson Corporation Azioni (MCK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.08%
1.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):